Early pancreatic cancer detection #22d91e433413 · Evaluation
Run the locked external validation ↗
Waiting for a licensed independent cohort, sample-size plan, and protocol approval.
#ea696d1878e7BlockedOpen question
Can a blood-marker model distinguish stage I–II pancreatic ductal adenocarcinoma from cancer-free controls?
Proposed retrospective target: on a locked independent cohort, achieve at least 70% sensitivity at at least 99% specificity, report 95% confidence intervals and subgroups, and rule out patient leakage. Dataset access is pending; this would not establish screening benefit.
Proposed milestone · no accepted result claimedWaiting for a licensed independent cohort, sample-size plan, and protocol approval.
#ea696d1878e7